Switch to:
Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA: -25.64 (As of Today)

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Denali Therapeutics Inc's enterprise value is $1,388.8 Mil. Denali Therapeutics Inc's EBITDA for the trailing twelve months (TTM) ended in Mar. 2019 was $-54.2 Mil. Therefore, Denali Therapeutics Inc's EV-to-EBITDA for today is -25.64.

NAS:DNLI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -41   Max: -6.4
Current: -25.64

-41
-6.4

During the past 4 years, the highest EV-to-EBITDA of Denali Therapeutics Inc was -6.40. The lowest was -41.00. And the median was -15.40.

NAS:DNLI's EV-to-EBITDA is ranked lower than
99.99% of the 281 Companies
in the Global industry.

( Industry Median: 18.08 vs. NAS:DNLI: -25.64 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today, Denali Therapeutics Inc's stock price is $19.63. Denali Therapeutics Inc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2019 was $-0.59. Therefore, Denali Therapeutics Inc's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Inc Annual Data

Dec15 Dec16 Dec17 Dec18
EV-to-EBITDA 0.00 0.00 -11.05 -38.10

Denali Therapeutics Inc Quarterly Data

Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.34 -8.43 -12.02 -38.10 -31.75

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Distribution

* The bar in red indicates where Denali Therapeutics Inc's EV-to-EBITDA falls into.



Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Calculation

Denali Therapeutics Inc's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1388.759/-54.168
=-25.64

Denali Therapeutics Inc's current Enterprise Value is $1,388.8 Mil.
Denali Therapeutics Inc's EBITDA for the trailing twelve months (TTM) ended in Mar. 2019 was -55.527 (Jun. 2018 ) + -35.637 (Sep. 2018 ) + 77.101 (Dec. 2018 ) + -40.105 (Mar. 2019 ) = $-54.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Denali Therapeutics Inc's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=19.63/-0.59
=

Denali Therapeutics Inc's share price for today is $19.63.
Denali Therapeutics Inc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2019 was -0.59 (Jun. 2018 ) + -0.38 (Sep. 2018 ) + 0.79 (Dec. 2018 ) + -0.41 (Mar. 2019 ) = $-0.59.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Related Terms


Denali Therapeutics Inc  (NAS:DNLI) EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}